Ana Ferreiro Selected Research

Early-Onset Myopathy with Fatal Cardiomyopathy

6/2008	Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies.
4/2007	C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Ferreiro Research Topics

Disease

24	Muscular Diseases (Myopathy) 01/2021 - 10/2002
7	Muscular Dystrophies (Muscular Dystrophy) 01/2017 - 10/2002
6	Minicore Myopathy with External Ophthalmoplegia 05/2008 - 06/2002
5	Central Core Myopathy (Central Core Disease) 01/2021 - 06/2002
4	Malignant Hyperthermia 01/2021 - 05/2003
3	Desmin-Related Myofibrillar Myopathy 01/2022 - 05/2004
2	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2021 - 05/2008
2	Muscle Weakness 01/2021 - 01/2019
2	Bethlem myopathy 01/2021 - 10/2010
2	Scleroatonic muscular dystrophy 01/2021 - 10/2010
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 06/2011 - 06/2008
2	Inborn Genetic Diseases (Disease, Hereditary) 04/2010 - 06/2009
2	Early-Onset Myopathy with Fatal Cardiomyopathy 06/2008 - 04/2007
1	Muscle Hypotonia (Hypotonia) 01/2021
1	Restrictive Cardiomyopathy 12/2020
1	Cardiomyopathies (Cardiomyopathy) 12/2020
1	Laminopathies 01/2019
1	Insulin Resistance 01/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Ventricular Tachycardia 01/2019
1	Glucose Intolerance 01/2019
1	Glycogen Storage Disease Type II (Pompe's Disease) 12/2018
1	Progeria (Hutchinson Gilford Syndrome) 01/2017
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2017
1	Type 2J Limb-Girdle Muscular Dystrophy 06/2008
1	Disease Progression 05/2008
1	Cataract (Cataracts) 11/2006
1	Myofibrillar Myopathy 11/2006
1	Macrophagic myofasciitis 11/2005
1	Ophthalmoplegia (External Ophthalmoplegia) 05/2003
1	Rigid spine syndrome 10/2002

Drug/Important Bio-Agent (IBA)

11	Selenoproteins (Selenoprotein)IBA 01/2019 - 10/2002
10	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 06/2002
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2007
4	DesminIBA 01/2022 - 05/2004
4	ConnectinIBA 01/2021 - 04/2007
4	CollagenIBA 01/2021 - 10/2010
3	Extracellular Matrix ProteinsIBA 01/2021 - 10/2010
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2006
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 04/2012
2	AntioxidantsIBA 01/2017 - 04/2012
2	SelenocysteineIBA 03/2009 - 04/2006
1	VinculinIBA 01/2022
1	Biological ProductsIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Dietary Fats (Dietary Fat)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Calcium Channels (Calcium Channel)IBA 01/2017
1	DystrophinIBA 01/2017
1	ChromatinIBA 01/2017
1	Lamin Type A (Lamin A)IBA 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Oxidants (Oxidizing Agents)IBA 04/2012
1	2,2,2',4'-tetrachloroacetophenoneIBA 06/2011
1	ElementsIBA 03/2009
1	Phosphotransferases (Kinase)IBA 04/2007
1	CalciumIBA 01/2007
1	Crystallins (Crystallin)IBA 11/2006
1	3' Untranslated Regions (3' UTR)IBA 04/2006
1	Messenger RNA (mRNA)IBA 04/2006
1	VaccinesIBA 11/2005

Therapy/Procedure

1	Therapeutics 01/2021
1	Heart Transplantation (Grafting, Heart) 12/2020
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2019
1	Palliative Care (Palliative Therapy) 12/2010